Rheumatology Therapeutics Market Set to Expand from $40.45 Billion in 2023 to $51.42 Billion in 2028 - Global Long-term Forecast to 2033
10 oct. 2024 11h23 HE
|
Research and Markets
Dublin, Oct. 10, 2024 (GLOBE NEWSWIRE) -- The "Rheumatology Therapeutics Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global rheumatology therapeutics market...
Blau Syndrome Market Report 2024-2034: Epidemiology, Industry Trends, Share, Size and Growth Forecast
12 juin 2024 10h45 HE
|
Research and Markets
Dublin, June 12, 2024 (GLOBE NEWSWIRE) -- The "Blau Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report has been added to ...
Global Axial Spondyloarthritis Market to Reach USD 8.79 Billion by 2030 Amid Advancements in Treatment Modalities and Drug Classes
26 févr. 2024 17h25 HE
|
Research and Markets
Dublin, Feb. 26, 2024 (GLOBE NEWSWIRE) -- The "Global Axial Spondyloarthritis Market by Type (Ankylosing Spondylitis (AS), Non-Radiographic Axial Spondyloarthritis (nr-axSpA))), Drug Class...
Global Ankylosing Spondylitis Market is Projected to Reach $7.29 Billion by 2027: Leading Players Pfizer, AbbVie, and Novartis Drive Advances in Treatment Options
12 oct. 2023 07h03 HE
|
Research and Markets
Dublin, Oct. 12, 2023 (GLOBE NEWSWIRE) -- The "Ankylosing Spondylitis Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global ankylosing spondylitis...